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Background:  Stress-induced cardiomyopathy (SCMP) is an increasingly recognized disease entity, however, the clinical features and outcomes of 
SCMP in a cancer patient population are not known.
Methods:  Between July 2008 and June 2010, 430 consecutive cancer patients underwent coronary angiography for abnormal cardiovascular 
test or acute coronary syndrome in a tertiary center. Inclusion criterion was: (1) acute coronary syndrome based on symptoms, an abnormal 
electrocardiogram, and/or elevated serum cardiac markers; (2) wall motion abnormality on echocardiography beyond a single epicardial coronary 
distribution; (3) no significant occlusive epicardial coronary artery disease or observed vasospasm.
Results:  From 39 patients diagnosed with acute coronary syndrome with positive cardiac biomarkers, 11 patients (28%) (Median age = 70 years) 
were diagnosis of SCMP, women comprising 82% of the patients. Triggering events were acute medical illness (i.e. sepsis) in 27.3% of patients, 
in-hospital surgery or procedures (i.e. thoracocenthesis) in 27.3% of patients, post chemotherapy 36.3% and emotional stress in 9% of patients. 
Median ejection fraction was 40-44% and peak troponin I median value was 1.63 ng/mL. ECG abnormalities were present in all patients, with ST 
segment depression was present in 9%, ST segment elevation was seen in 18%, T wave inversion was observed in 64%, and LBBB 9%. Typical apical 
ballooning was present in all patients. Additional echocardiographic strain analysis and cardiac magnetic resonance imaging was performed in 
selected patients. The patients where treated medically for their cardiomyopathy. Admission to intensive care unit (ICU) was required in 10/11 
patients (91 %), with an overall survival at 6 months of 82%.
Conclusions:  Apical ballooning syndrome is under recognized and often misdiagnosed. Cancer patient population has increased vulnerability 
(infection, surgery, chemotherapy, stress) as suggested by the higher incidence of SCMP, but good intermediate term prognosis. SCMP should be 
strongly considered in the differential diagnosis of cancer patients presenting with an acute cardiomyopathy or an acute coronary syndrome.
